Twenty-two years after the approval of the Brazilian Patent Law (Law 9.279/96), the obligation (article 229-C) for all pharmaceutical patents to be subject to prior approval by ANVISA (National Health Surveillance Agency, equivalent…
Read more
When we talk about cosmetics, we inevitably talk about formulas, processes or procedures embodied in certain products that help us to care for, improve and beautify aspects of our skin. Nowadays, there are…
Read more
On 1 December 2020, INPI/PR Normative Instruction No. 118/2020 was published in the Industrial Property Journal (RPI) and came into force, which establishes the new Guidelines for the Examination of Patent Applications in…
Read more
On October 16, 2020, the Provincial Court of Barcelona issued a ruling that we consider very interesting and which provides an answer to the question of what should happen in an ongoing dispute…
Read more
On November 5th, 2020, in view of the entry into force of the #USMCA, #ACEUM, (July 1, 2020) and the #HagueAgreement (June 6, 2020), Mexico launches its new FEDERAL LAW FOR THE PROTECTION…
Read more
The Argentinian Federal Court has recently confirmed that a third party may not be entitled to intervene as third party at a Court level. In Actelion Pharmaceuticals v. the Patent Office of Argentina,…
Read more
This month of September/2020 has started with news from the Brazilian Patent and Trademark Office as regards to patents. Priority Examination Two additional priority examinations have been allowed as of September 1st which…
Read more
On Wednesday July 29th, 2020 – 12.30pm EST (New York) / 6.30pm CEST (Paris) we will be hosting a Webinar on Privacy, Cybersecurity and Telecommunications in Latin-America with a widely experienced panel. We…
Read more
On Tuesday June 30th, 2020 – 12.30pm EST (New York) / 6.30pm CEST (Paris) we hosted a Webinar on Antibody Patenting in Latin-America with an experienced panel. We tried to throw some light…
Read more